
Julia Dawn (Quinlan) Mahaney DO FAPA, FASAM
Psychopharmacology, Women Focused, Integrative Psychiatry
Psychiatrist
Overview of Dr. Mahaney
Board Certified by the American Board of Psychiatry and Neurology and Board Certified by the American Board of Preventive Medicine in Addiction.
Board Certified by the American Osteopathic Association in both Psychiatry and Addiction Medicine.
Retired USAF (Flight Surgeon)
Education & Training
 University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Psychiatry, 2001 - 2005 University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Psychiatry, 2001 - 2005
 Texas College of Osteopathic MedicineClass of 2001 Texas College of Osteopathic MedicineClass of 2001
Certifications & Licensure
 DE State License 2022 - 2027 DE State License 2022 - 2027
 IN State License 2002 - 2027 IN State License 2002 - 2027
 SC State License 2024 - 2027 SC State License 2024 - 2027
 TX State License 2017 - 2027 TX State License 2017 - 2027
 NY State License 2019 - 2026 NY State License 2019 - 2026
 PA State License 2021 - 2026 PA State License 2021 - 2026
 NJ State License 2020 - 2025 NJ State License 2020 - 2025
 American Board of Psychiatry and Neurology Psychiatry American Board of Psychiatry and Neurology Psychiatry
 AOA Board of Neurology and Psychiatry Addiction Medicine (CAQ) AOA Board of Neurology and Psychiatry Addiction Medicine (CAQ)
 AOA Board of Neurology and Psychiatry Psychiatry AOA Board of Neurology and Psychiatry Psychiatry
 American Board of Preventive Medicine Addiction Medicine American Board of Preventive Medicine Addiction Medicine
Awards, Honors, & Recognition
- Meritorious Service Medal, First Oak Leaf Cluster United States Air Force
- Physician Quality Champion/Good Catch Award Biannual, Quarter 1 and 2 Methodist Specialty and Transplant Hospital, 2018
- AFMC Behavioral Health Flight of the Year Award United States Air Force, 2007
- Join now to see all
Clinical Trials
- Cocaine Use Reduction With Buprenorphine Start of enrollment: 2011 Sep 01
Committees
- Lead, Safe Benzodiazepine Prescribing Quality Improvement Project 2019 - 2020
- Clinical Director, Opioid Overdose Prevention Program (SUNY) Stony Brook Outpatient Psychiatry Clinic 2019 - 2020
- Member, Metabolic Screening/Cardiovascular Risks, QI project, Stony Brook University 2019 - 2019
- Member, Pain Management Oversight Program 2018 - 2019
- Physician Representative, Physician Representative for Clinic Pharmacy Executive Advisory Board VISN 17 2015 - 2017
- Pain Committee Chair, Pain Committee Chair Audie L. Murphie VA Hospital 2015 - 2017
- Facility Pain POC, Pain Point of Care and Opioid Safety Initiative Representative 2014 - 2018
- Co-Champion/Lead, Opioid Education Naloxone Education (OEND) Initiative 2014 - 2018
Research History
- Cocaine Use Reduction with Buprenorphine (CURB)Medical Clinician; Funding Source: The National Institute on Drug Abuse Clinical Trials Network; Location: UT Health Science Center San Antonio/South Texas VA Health Care System2011 - 2013
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









